GI Innovation allergic diseases treatment

South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...

Hyundai Motor Group said on Thursday it has signed a strategic partnership agreement with Japan's Toray Industries Inc. to jointly develop carbon fi...

SK Innovation Co., South Korea’s top energy company, is slated to adjust its business portfolios for long-term growth while not planning to sl...

South Korea’s Lotte Innovate (formerly, Lotte Data Communication Co. ) announced that it signed a memorandum of understanding (MOU) with Kolon...

SK Innovation Co., South Korea’s top energy company, is reorganizing its subsidiaries to boost their individual values through independent man...

South Korean clothing company LF Corp. said on Monday that its street fashion brand Dunst will build an offline presence in China in partnership wit...

South Korea’s POSCO Future M Co. has been named Asia Future 30 by the US economic media Fortune on Mar. 27, according to the company on Thursd...

Ferrari S.p.A. joined hands with SK On Co., the world’s fifth-largest electric vehicle battery producer, to innovate cell technology as the It...

Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kit...

The Asan Nanum Foundation, a nonprofit foundation set up in 2011 to commemorate the 10th anniversary of Hyundai founder Chung Ju-yung’s death,...

Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...

South Korea’s online giant Naver Corp. ranked as the third most innovative company in the Asia-Pacific by a top US business magazine for the p...

Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...

Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...

South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...

South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and developmen...

Kakao Brain, an artificial intelligence (AI) R&D subsidiary of South Korea's Kakao Corp., announced on Tuesday that it has uploaded the Labeler ...

South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...

Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digi...

South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., said on Sunday it has launched an artificial intelligence center to stre...

South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...

The state-run Korea Development Bank (KDB) announced on Friday that it has established the KDB-Quantum Mobility Value Chain Open Innovation Fund wor...

ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...